Cargando…

Integrating machine learning to construct aberrant alternative splicing event related classifiers to predict prognosis and immunotherapy response in patients with hepatocellular carcinoma

Introduction: In hepatocellular carcinoma (HCC), alternative splicing (AS) is related to tumor invasion and progression. Methods: We used HCC data from a public database to identify AS subtypes by unsupervised clustering. Through feature analysis of different splicing subtypes and acquisition of the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Wangrui, Zhao, Shuai, Xu, Wenhao, Xiang, Jianfeng, Li, Chuanyu, Li, Jun, Ding, Han, Zhang, Hailiang, Zhang, Yichi, Huang, Haineng, Wang, Jian, Wang, Tao, Zhai, Bo, Pan, Lei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9573973/ https://www.ncbi.nlm.nih.gov/pubmed/36263133 http://dx.doi.org/10.3389/fphar.2022.1019988

Ejemplares similares

Integrating m6A Regulators-Mediated Methylation Modification Models and Tumor Immune Microenvironment Characterization in Caucasian and Chinese Low-Grade Gliomas
por: Liu, Wangrui, et al.
Publicado: (2021)

Malignant Tumor Purity Reveals the Driven and Prognostic Role of CD3E in Low-Grade Glioma Microenvironment
por: Lu, Xiuqin, et al.
Publicado: (2021)

Integrated machine learning and bioinformatic analyses used to construct a copper-induced cell death-related classifier for prognosis and immunotherapeutic response of hepatocellular carcinoma patients
por: Zhao, Shuai, et al.
Publicado: (2023)

Network pharmacological systems study of Huang-Lian-Tang in the treatment of glioblastoma multiforme
por: Liu, Wangrui, et al.
Publicado: (2021)

Aberrant alternative splicing in breast cancer
por: Yang, Quan, et al.
Publicado: (2019)

Comprehensive Multi-Omics Identification of Interferon-γ Response Characteristics Reveals That RBCK1 Regulates the Immunosuppressive Microenvironment of Renal Cell Carcinoma
por: Xu, Wenhao, et al.
Publicado: (2021)

Elevated double-strand break repair protein RAD50 predicts poor prognosis in hepatitis B virus-related hepatocellular carcinoma: A study based on Chinese high-risk cohorts
por: Liu, Wangrui, et al.
Publicado: (2020)

Melatonin inhibits HCC progression through regulating the alternative splicing of NEMO
por: Bai, Lu, et al.
Publicado: (2022)

Pan-Cancer Analysis Reveals Alternative Splicing Characteristics Associated With Immune-Related Adverse Events Elicited by Checkpoint Immunotherapy
por: He, Xiujing, et al.
Publicado: (2021)

Aberrant splicing in human cancer: An RNA structural code point of view
por: Apostolidi, Maria, et al.
Publicado: (2023)

Transcriptome Profiles Reveal a 12-Signature Metabolic Prediction Model and a Novel Role of Myo-Inositol Oxygenase in the Progression of Prostate Cancer
por: Liu, Wangrui, et al.
Publicado: (2022)

Splicing predictions reliably classify different types of alternative splicing
por: Busch, Anke, et al.
Publicado: (2015)

LXR agonist inhibits inflammation through regulating MyD88 mRNA alternative splicing
por: Li, Ni, et al.
Publicado: (2022)

Multi-omics profiles refine L-dopa decarboxylase (DDC) as a reliable biomarker for prognosis and immune microenvironment of clear cell renal cell carcinoma
por: Chang, Kun, et al.
Publicado: (2022)

Increased DNA Polymerase Epsilon Catalytic Subunit Expression Predicts Tumor Progression and Modulates Tumor Microenvironment of Hepatocellular Carcinoma
por: Tang, Haijia, et al.
Publicado: (2022)

Tumor-associated macrophage-derived chemokine CCL5 facilitates the progression and immunosuppressive tumor microenvironment of clear cell renal cell carcinoma
por: Xu, Wenhao, et al.
Publicado: (2022)

Aberrant Alternative Splicing Is Another Hallmark of Cancer
por: Ladomery, Michael
Publicado: (2013)

Deep Splicing Code: Classifying Alternative Splicing Events Using Deep Learning
por: Louadi, Zakaria, et al.
Publicado: (2019)

Comprehensively analysis of splicing factors to construct prognosis prediction classifier in prostate cancer
por: Zhang, He, et al.
Publicado: (2023)

Integrating machine learning and bioinformatics analysis to m6A regulator-mediated methylation modification models for predicting glioblastoma patients’ prognosis and immunotherapy response
por: Li, Chuanyu, et al.
Publicado: (2023)

Construction of anoikis-related lncRNAs risk model: Predicts prognosis and immunotherapy response for gastric adenocarcinoma patients
por: Li, Qinglin, et al.
Publicado: (2023)

An exonic splicing enhancer mutation in DUOX2 causes aberrant alternative splicing and severe congenital hypothyroidism in Bama pigs
por: Cao, Chunwei, et al.
Publicado: (2019)

Signature of gene aberrant alternative splicing events in pancreatic adenocarcinoma prognosis
por: Yao, Jun, et al.
Publicado: (2021)

Widespread alternative and aberrant splicing revealed by lariat sequencing
por: Stepankiw, Nicholas, et al.
Publicado: (2015)

Targeting alternative splicing in cancer immunotherapy
por: Han, Nan, et al.
Publicado: (2023)

A new molecular subclassification and in silico predictions for diagnosis and prognosis of papillary thyroid cancer by alternative splicing profile
por: Li, Haiyan, et al.
Publicado: (2023)

Role of global aberrant alternative splicing events in papillary thyroid cancer prognosis
por: Lin, Peng, et al.
Publicado: (2019)

Serine and glycine metabolism-related gene expression signature stratifies immune profiles of brain gliomas, and predicts prognosis and responses to immunotherapy
por: Chen, Siliang, et al.
Publicado: (2022)

Comprehensive bioinformatic analysis constructs a CXCL model for predicting survival and immunotherapy effectiveness in ovarian cancer
por: Li, Shuang, et al.
Publicado: (2023)

Multi-omics reveals novel prognostic implication of SRC protein expression in bladder cancer and its correlation with immunotherapy response
por: Xu, Wenhao, et al.
Publicado: (2021)

Given Dimensions of Neoplastic Events as Aberrantly Operative Alternative Splicing
por: Agius, Lawrence M.
Publicado: (2009)

Aberrant spliceosome expression and altered alternative splicing events correlate with maturation deficiency in human oocytes
por: Li, Junsheng, et al.
Publicado: (2020)

Comprehensive analysis of aberrant alternative splicing related to carcinogenesis and prognosis of papillary thyroid cancer
por: Zheng, Xiaobo, et al.
Publicado: (2021)

A novel 16-gene alternative mRNA splicing signature predicts tumor relapse and indicates immune activity in stage I–III hepatocellular carcinoma
por: Chen, Xu-Xiao, et al.
Publicado: (2022)

The prognostic significance of global aberrant alternative splicing in patients with myelodysplastic syndrome
por: Yang, Yi-Tsung, et al.
Publicado: (2018)

Ginsenosides: Allies of gastrointestinal tumor immunotherapy
por: Feng, Yutao, et al.
Publicado: (2022)

Role of alternative splicing of VEGF-A in the development of atherosclerosis
por: Zhao, Naishi, et al.
Publicado: (2018)

Identification of TGF-β signaling-related molecular patterns, construction of a prognostic model, and prediction of immunotherapy response in gastric cancer
por: Zeng, Cheng, et al.
Publicado: (2022)

Rechallenge of immunotherapy beyond progression in patients with extensive-stage small-cell lung cancer
por: Li, Lingling, et al.
Publicado: (2022)

A novel score system based on arginine metabolism-related genes to predict prognosis, characterize immune microenvironment, and forecast response to immunotherapy in IDH-wildtype glioblastoma
por: Feng, Wentao, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_npd2geknivtbdgtenc6l629akq